| 國立成功大學 |
2023 |
10-Year Outcomes of Patients With Non-Paroxysmal Atrial Fibrillation Undergoing Catheter Ablation
|
Tsai, Tsai T.-Y.;Lo, Lo L.-W.;Cheng, W.-H.;Liu, S.-H.;Lin, Y.-J.;Chang, S.-L.;Hu, Y.-F.;Chung, F.-P.;Liao, J.-N.;Tuan, Tuan T.-C.;Chao, T.-F.;Lin, C.-Y.;Chang, T.-Y.;Liu, C.-M.;Chheng, Chheng C.;Hermanto, D.Y.;An, T.N.;Elimam, A.M.M.;Huang, T.-C.;Lee, P.-T.;Lee, C.-H.;Chen, S.-A. |
| 國立成功大學 |
2023 |
Subendocardial haemorrhage prohibits the success of catheter ablation in a prolonged ventricular tachycardia procedure: a case report
|
Su, P.-H.;Chen, Chen C.-Y.;Huang, T.-C. |
| 國立成功大學 |
2023 |
Comparison of the Results of Cardiopulmonary Exercise Testing between Healthy Peers and Pediatric Patients with Different Echocardiographic Severity of Mitral Valve Prolapse
|
Huang, M.-H.;Tuan, S.-H.;Tsai, Y.-J.;Huang, W.-C.;Huang, T.-C.;Chang, S.-T.;Lin, K.-L. |
| 國立成功大學 |
2023 |
Renal denervation reverses ventricular structural and functional remodeling in failing rabbit hearts
|
Huang, T.-C.;Lo, Lo L.-W.;Chou, Y.-H.;Lin, W.-L.;Chang, S.-L.;Lin, Y.-J.;Liu, S.-H.;Cheng, W.-H.;Liu, P.-Y.;Chen, S.-A. |
| 臺大學術典藏 |
2022-09-15T01:09:06Z |
Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors
|
Guo J.-C.; Chia-Chi Lin; Lin C.-Y.; Hsieh M.-S.; Kuo H.-Y.; Lien M.-Y.; Shao Y.-Y.; Huang T.-C.; Hsu C.-H. |
| 臺大學術典藏 |
2022-09-15T01:08:47Z |
Response to Immune Checkpoint Inhibitors in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma May Be Affected by Tumor Sites
|
Guo J.-C.; Lin C.-Y.; Chia-Chi Lin; Huang T.-C.; Lien M.-Y.; Lu L.-C.; Kuo H.-Y.; Hsu C.-H. |
| 臺大學術典藏 |
2022-09-15T01:08:43Z |
Prognostic value of PD-L1 expression on immune cells or tumor cells for locally advanced esophageal squamous cell carcinoma in patients treated with neoadjuvant chemoradiotherapy
|
Huang T.-C.; Liang C.-W.; Li Y.-I.; Guo J.-C.; Chia-Chi Lin; Chen Y.-J.; Cheng A.-L.; Hsu C.-H. |
| 臺大學術典藏 |
2022-08-23T02:35:03Z |
Polatuzumab vedotin�Vbased salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang Y.-W.; Tsai X.C.-H.; Hou H.-A.; Tien F.-M.; Liu J.-H.; Chou W.-C.; Ko B.-S.; Chen Y.-W.; Lin C.-C.; Cheng C.-L.; Lo M.-Y.; Lin Y.-C.; Lu L.-C.; Wu S.-J.; SUNG-HSIN KUO; Hong R.-L.; Huang T.-C.; Yao M. |
| 臺大學術典藏 |
2022-08-19T06:48:44Z |
Response to Immune Checkpoint Inhibitors in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma May Be Affected by Tumor Sites
|
Guo J.-C.; Lin C.-Y.; Lin C.-C.; Huang T.-C.; Lien M.-Y.; Lu L.-C.; Kuo H.-Y.; CHIH-HUNG HSU |
| 臺大學術典藏 |
2022-08-19T00:21:09Z |
Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies
|
Huang T.-C.; Ko B.-S.; Tang J.-L.; CHIUN HSU; Chen C.-Y.; Tsay W.; Huang S.-Y.; Yao M.; Chen Y.-C.; Shen M.-C.; Wang C.-H.; Tien H.-F. |
